Panacea Biotec · NSE: PANACEABIO · BSE: 531349
Q1 FY19 results · Apr–Jun 2018
Panacea Biotec reported revenue from operations of ₹95.11 crore and net loss of ₹36.83 crore for Q1 FY19 (Apr–Jun 2018), on a standalone basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 95.11 | — | — | — | — |
| Other income | 3.33 | — | — | — | — |
| Total income | 98.44 | — | — | — | — |
| Profit before tax | (34.17) | — | — | — | — |
| Net profit for the period | (36.83) | — | — | — | — |
| EPS, basic (₹) | (6.01) | — | — | — | — |
| Net margin (%) | -38.7 | — | — |
Standalone
- Filed with BSE
- 20 Aug 2018, 12:14 IST
- Board meeting
- 14 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE